ORGANON & CO. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.75 USD | -0.09% |
|
+1.64% | +50.49% |
| May. 08 | Organon Reports Pricing of $1 Billion Senior Notes Offering | MT |
| May. 08 | Organon & Co. and Organon Foreign Debt Co-Issuer B.V. Announces Pricing of $1.0 Billion Senior Notes Offering | CI |
Presenter SpeechSteve Scala (Analysts)Good morning, and welcome to the Organon session of Cowe...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Companyâs Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. The Company operates six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.
Sector
Pharmaceuticals
Calendar
2024-06-04
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
21.77
USD
Average target price
22.5
USD
Spread / Average Target
+3.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.49% | 5.6B | |
| +38.96% | 705B | |
| +32.57% | 583B | |
| -3.06% | 364B | |
| +21.34% | 332B | |
| +6.05% | 291B | |
| +16.21% | 238B | |
| -3.56% | 210B | |
| +10.52% | 209B | |
| +9.38% | 169B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Transcript : Organon & Co. Presents at 42nd Annual Cowen Health Care Conference, Mar-09-2022 09